Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04551495
Title Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Age Groups: adult | senior
Covered Countries FRA | BEL

No variant requirements are available.